{
  "generated": "2025-10-23T09:24:42.756902+00:00",
  "policy_fingerprint": "0xbe3a798944b1c64b",
  "source_evidence": "entries/physiological/garlic-card-gar-chole/cardiovascular/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "CARD-GAR-CHOLE_01",
      "year": 2006,
      "design": "randomized controlled trial",
      "journal": "cardiovascular_journal",
      "outcome": "cholesterol",
      "population": "Adults with cholesterol concerns",
      "adverse_events": "Mild GI discomfort",
      "doi": "10.1234/card-gar-chole-01",
      "url": "https://doi.org/10.1234/card-gar-chole-01",
      "citation": "CARD-GAR-CHOLE_01 (2006); Journal: cardiovascular_journal; Design: randomized controlled trial; Population: Adults with cholesterol concerns; Outcome: cholesterol; DOI: 10.1234/card-gar-chole-01; Adverse Events: Mild GI discomfort."
    },
    {
      "study_id": "CARD-GAR-CHOLE_02",
      "year": 2007,
      "design": "randomized controlled trial",
      "journal": "cardiovascular_journal",
      "outcome": "cholesterol",
      "population": "Adults with cholesterol concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/card-gar-chole-02",
      "url": "https://doi.org/10.1234/card-gar-chole-02",
      "citation": "CARD-GAR-CHOLE_02 (2007); Journal: cardiovascular_journal; Design: randomized controlled trial; Population: Adults with cholesterol concerns; Outcome: cholesterol; DOI: 10.1234/card-gar-chole-02; Adverse Events: Transient headache."
    },
    {
      "study_id": "CARD-GAR-CHOLE_03",
      "year": 2008,
      "design": "randomized controlled trial",
      "journal": "cardiovascular_journal",
      "outcome": "cholesterol",
      "population": "Adults with cholesterol concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/card-gar-chole-03",
      "url": "https://doi.org/10.1234/card-gar-chole-03",
      "citation": "CARD-GAR-CHOLE_03 (2008); Journal: cardiovascular_journal; Design: randomized controlled trial; Population: Adults with cholesterol concerns; Outcome: cholesterol; DOI: 10.1234/card-gar-chole-03; Adverse Events: None reported."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/card-gar-chole-01",
      "study_ids": [
        "CARD-GAR-CHOLE_01"
      ],
      "primary_study_id": "CARD-GAR-CHOLE_01",
      "url": "https://doi.org/10.1234/card-gar-chole-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/card-gar-chole-02",
      "study_ids": [
        "CARD-GAR-CHOLE_02"
      ],
      "primary_study_id": "CARD-GAR-CHOLE_02",
      "url": "https://doi.org/10.1234/card-gar-chole-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/card-gar-chole-03",
      "study_ids": [
        "CARD-GAR-CHOLE_03"
      ],
      "primary_study_id": "CARD-GAR-CHOLE_03",
      "url": "https://doi.org/10.1234/card-gar-chole-03"
    }
  ],
  "manifest_hash": "sha256:73262a045bf7f1b43a707633ac67b2fb999d1b7081b5092e9fedfc8ecbe3aadd"
}
